Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double Blind, Controlled Study Evaluating Safety and Preliminary Efficacy of a Single Injection of Adult Mesenchymal Precursor Cells (MPCs) Combined With Hyaluronan in Subjects With Chronic Discogenic Lumbar Back Pain

NCT01290367 is registered in ClinicalTrials.gov with Mesoblast, Ltd. as lead sponsor.

NCT NCT01290367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double Blind, Controlled Study Evaluating Safety and Preliminary Efficacy of a Single Injection of Adult Mesenchymal Precursor Cells (MPCs) Combined With Hyaluronan in Subjects With Chronic Discogenic Lumbar Back Pain
Lead sponsor
Mesoblast, Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
July 31, 2015
Enrollment
100 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease